Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Self-Monitoring Blood Glucose (SMBG) Devices Market by the end of 2030?
The market size for self-monitoring blood glucose (smbg) devices has shown strong growth in recent years. It is anticipated to increase from $16.19 billion in 2025 to $17.56 billion in 2026, at a compound annual growth rate (CAGR) of 8.5%. The historical expansion of this market can be attributed to the rising prevalence of diabetes, increased recognition of self-monitoring practices, broader adoption of home healthcare, the availability of affordable glucose meters, and refined diabetes management guidelines.
The self-monitoring blood glucose (smbg) devices market is anticipated to experience robust expansion over the coming years. Its size is projected to reach $24.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This growth during the forecast period is attributable to several factors, including the escalating demand for connected health solutions, the rising integration of continuous glucose monitoring, the broadening of telehealth-based diabetes care, an intensifying focus on preventive healthcare, and increased investments in digital diabetes management. Key trends anticipated within the forecast timeframe encompass the increasing uptake of smart glucose monitoring devices, a growing reliance on continuous glucose monitoring systems, the expanding incorporation of mobile health applications, the extension of remote patient monitoring solutions, and an elevated emphasis on designing patient-friendly devices.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6969&type=smp
What Drivers Are Shaping Future Opportunities In The Self-Monitoring Blood Glucose (SMBG) Devices Market?
The expanding occurrence of diabetes is projected to fuel the expansion of the self-monitoring blood glucose device market in the future. Diabetes is defined as a persistent metabolic condition where the body either fails to produce sufficient insulin or cannot utilize it effectively, resulting in elevated blood glucose levels that can eventually harm various organs and systems. This increasing prevalence of diabetes largely stems from unhealthy eating habits that contribute to prolonged high blood sugar and progressively stress metabolic health over time. Self-Monitoring Blood Glucose (SMBG) Devices assist in managing diabetes by allowing individuals to monitor their real-time blood sugar levels, facilitating prompt adjustments to diet, medication, or physical activity for improved glycemic control. For instance, in June 2024, as reported by the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total count of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a notable increase compared to 3,065,825 in 2022, signifying a rise of nearly 20%. Consequently, the growing incidence of diabetes is driving the expansion of the self-monitoring blood glucose devices market.
Which Segments Are Gaining Traction In The Self-Monitoring Blood Glucose (SMBG) Devices Market?
The self-monitoring blood glucose (smbg) devices market covered in this report is segmented –
1) By Product: Self-Monitoring Blood Glucose Meters, Testing Strips, Lancets
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers
3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
Subsegments:
1) By Self-Monitoring Blood Glucose Meters: Traditional Glucose Meters, Smart Glucose Meters
2) By Testing Strips: Standard Testing Strips, Test Strips for Specific Meters
3) By Lancets: Standard Lancets, Safety Lancets
How Are New Market Trends Shaping The Landscape Of The Self-Monitoring Blood Glucose (SMBG) Devices Market?
Leading companies in the self-monitoring blood glucose (SMBG) devices market are concentrating on developing innovative solutions, such as continuous glucose monitoring (CGM) systems. This effort aims to address the growing demand for less burdensome glucose tracking, improved glycemic control, remote patient monitoring, and better integration with insulin delivery and digital health platforms. CGM systems function as wearable sensors that continuously measure interstitial glucose, providing trend data, alerts, and cloud-connected reporting. Their key features include real-time glucose readings, trend arrows, customizable alarms, and data sharing capabilities. Unlike traditional fingerstick SMBG (glucometers), which require discrete capillary blood samples and offer only point-in-time values, CGMs enable proactive therapy adjustments and richer longitudinal insights, thereby reducing hypoglycemia risk and improving time-in-range. For example, in August 2024, Medtronic plc, an Ireland-based medical technology company, launched Simplera CGM. This compact, disposable, all-in-one continuous glucose monitor is designed for easier self-application, real-time glucose sensing, and seamless use with both the InPen smart insulin pen and the MiniMed 780G system. It offers users a smaller form factor, simplified wear, and enhanced interoperability, supporting continuous visibility for Smart MDI users, redundant sensing for pump users, and overall improved comfort, adherence, and clinical decision-making through continuous glucose trend data integration.
Who Are The Top-Performing Companies In The Self-Monitoring Blood Glucose (SMBG) Devices Market In Recent Years?
Major companies operating in the self-monitoring blood glucose (smbg) devices market are Abbott Laboratories, Bionime Corporation, B Braun Melsungen AG, F Hoffmann La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Senseonics Holdings Inc, AgaMatrix Inc, All Medicus Co Ltd, Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Cnoga Medical Ltd, ForaCare Inc, Infopia Co Ltd, Menarini Diagnostics, Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc, OrSense Ltd, Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Self-Monitoring Blood Glucose (SMBG) Devices Market?
North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the self-monitoring blood glucose (smbg) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Self-Monitoring Blood Glucose (SMBG) Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6969&type=smp
Browse Through More Reports Similar to the Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2026, By The Business Research Company
Continuous Glucose Monitoring Devices Global Market Report 2026
Blood Glucose Monitoring Systems Global Market Report 2026
Continous Blood Glucose Monitoring Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company